ArticleClinical rheumatology2018
Early hearing loss detection in rheumatoid arthritis and primary Sjögren syndrome using extended high frequency audiometry.
Article in Clinical rheumatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Audiological Features in Patients with Rheumatoid Arthritis: A Systematic Review.International journal of molecular sciences · 2024Pooled it
- Secondary autoimmune immune ear disease (AIED): a systematic review and meta-analysis on vestibular manifestations of systemic autoimmune and inflammatory disorders.Clinical rheumatology · 2023Pooled it
- Sensorineural Hearing Loss in Autoimmune Diseases: A Systematic Review and Meta-analysis.The journal of international advanced otology · 2023Pooled it
- Association of rheumatoid arthritis with hearing loss: a systematic review and meta-analysis.Rheumatology international · 2020Pooled it
- Sensorineural Hearing Loss in Major Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2026Review
- Subclinical sensorineural hearing loss in systemic lupus erythematosus: a comparative cross-sectional study.Clinical rheumatology · 2025Article
- Association Between Hearing Loss and Systemic Small-Vessel Vasculitis: Audiological Aspects Across Disease Types.Medicina (Kaunas, Lithuania) · 2025Article
- Hearing Loss in Connective Tissue Diseases: A Systematic Review.European journal of rheumatology · 2025Article
- The Effect of Rheumatoid Arthritis on Middle and Inner Ear Functions.Turkish archives of otorhinolaryngology · 2024Article
- Increased prevalence of hearing loss, tinnitus and sudden deafness among patients with Sjögren's syndrome.RMD open · 2024Article
- Hearing Function in Adults with Rheumatoid Arthritis: A Scoping Review for Preventive Audiology Planning.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022Article
- Sensorineural Hearing Loss in Sjögren's Syndrome.International journal of molecular sciences · 2022Review
- Article
- Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolving Responses.International journal of molecular sciences · 2021Review
- Brainstem auditory evoked potentials in patients with primary Sjögren's syndrome without central nervous system involvement.Clinical rheumatology · 2021Article
- Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndromeTurkish journal of medical sciences · 2019Article
- Hearing status in patients with rheumatoid arthritis.Caspian journal of internal medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study is to evaluate the hearing behavior of rheumatoid arthritis (RA) and primary Sjögren syndrome (PSS) patients and compare them with a healthy control group and with each other. A comparative cross-sectional study was performed with a group of 117 female RA patients, a group of 60 female PSS patients, and a 251 female healthy control group. Every subject underwent a series of studies including high-frequency audiometry, speech audiometry, and tympanometry. The high-frequency audiometry measured 250 to 16,000 Hz. The 117 patients with RA and the 60 with PSS were diagnosed according to American College of Rheumatology criteria / ACR 2010, and the validated classification of the American-European Consensus Group. Hearing loss was present in 36.8% of the RA group in 500-3000 Hz, 68.4% in 4000-8000 Hz, and 94.9% in 10,000-16,000 Hz. Hearing loss was present in 60% of the PSS group in 500-3000 Hz, 70% in 4000-8000 Hz, and 100% in 10,000-16,000 Hz. The hearing impairment prevalence of both groups was significantly different (p < 0.05) when compared with the healthy control group. We also compared the hearing thresholds between RA and PSS patients, finding a significant hearing threshold increase in 500-3000 Hz of the PSS group. This study consolidates the association between RA and PSS with hearing impairment. A deeper hearing loss was reported in PSS than in RA patients, demonstrating a greater auditory and speech recognition repercussion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.